Female alloimmunization with antibodies known to cause hemolytic disease

Obstetrics and Gynecology

Volumn 89, Issue 2, 1997, Pages 272-275

  Geifman Holtzman, Ossie ^a   Wojtowycz, Martha ^a   Kosmas, Eleni ^a   Artal, Raul ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIBODY; BLOOD GROUP ANTIGEN; ERYTHROCYTE ANTIGEN; RHESUS C ANTIBODY; RHESUS D ANTIBODY; RHESUS E ANTIBODY;

ADOLESCENT; ADULT; ALLOIMMUNIZATION; ANTIBODY DETECTION; ARTICLE; BLOOD GROUP DUFFY SYSTEM; BLOOD GROUP KELL SYSTEM; BLOOD GROUP KIDD SYSTEM; BLOOD GROUP LEWIS SYSTEM; BLOOD GROUP MNSS SYSTEM; DEMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; NEWBORN HEMOLYTIC DISEASE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANEMIA, HEMOLYTIC; ERYTHROCYTES; FEMALE; HUMANS; ISOANTIBODIES; ISOANTIGENS;

EID: 0031080817     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(96)00434-6     Document Type: Article

References (18)

1. 1. Weinstein L. Irregular antibodies causing hemolytic disease of the newborn: A continuing problem. Clin Obstet Gynecol 1982;25:321-32.
2. 2. Bowman J. Hemolytic disease. In: Creasy R, Resnic R, eds. Maternal-fetal medicine. Philadelphia: WB Saunders, 1989:613-55.
3. 3. Moise KJ. Changing trends in the management of red blood cell alloimmunization in pregnancy. Arch Pathol Lab Med 1994;118: 421-8.
4. 4. Berkowitz RL, Beyth Y, Sadovsky E. Death in utero due to Kell sensitization without elevation of the ΔOD450 value in amniotic fluid. Obstet Gynecol 1982;60:746-9.
5. 5. Stone B, Marsh WL. Haemolytic disease of the newborn caused by anti-M. Br J Haematol 1959;5:344-7.
6. a. Am J Obstet Gynecol 1975;121:643-5.
7. 7. Feldman R, Luhby AL, Gromisch DS. Erythroblastosis fetalis due to anti-s antibody. J Pediatr 1973;82:88-91.
8. a sensitization during pregnancy. Can Med Assoc J 1961;85:1048-9.
9. 9. Polesky HF. Blood group antibodies in prenatal sera. Minn Med 1967;50:601-3.
10. 10. Queenan JG, Smith BD, Haber JM, Jeffrey J, Gadow HC. Irregular antibodies in the obstetric patient. Obstet Gynecol 1969;34:767-70.
11. 11. Fisk NM, Benett P, Warwick R, Letsky EA, Welch R, Vaughan JI. Clinical utility of fetal RhD typing in alloimmunized pregnancies by means of polymerase chain reaction on amniocytes or chorionic villi. Am J Obstet Gynecol 1994;171:50-4.
12. 12. Pepperell RJ, Barrie JV, Fliegner JR. Significance of red cell irregular antibodies in the obstetric patient. Med J Aust 1977;2:453-6.
13. 13. Filbey D, Hanson U, Wesstrom G. The prevalence of red cell antibodies in pregnancy correlated to the outcome of the newborn: A 12 year study in central Sweden. Acta Obstet Gynecol Scand 1995;74:687-92.
14. 14. Solola A, Sibai B, Mason JM. Irregular antibodies: An assessment of routine prenatal screening. Obstet Gynecol 1983;61:25-30.
15. 15. Race RR, Sanger R. Blood groups in man. 6th ed. Oxford: Blackwell 1975:112.
16. 16. Geifman-Holtzman O, Bernstein MI, Berry SM, Bianchi DW, Holtzman EJ. Rapid molecular determination of fetal Rhesus E type. Prenat Diagn 1996;116:489-93.
17. 17. Van den Veyver IB, Chong SS, Cota J, Bennett PR, Fisk NM, Handyside AH, et al. Single-cell analysis of the RhD blood type for use in preimplantation diagnosis in the prevention of severe hemolytic disease of the newborn. Am J Obstet Gynecol 1995;172: 533-40.
18. 18. Geifman-Holtzman O, Bernstein IM, Berry SM, Holtzman EJ, Vadnais TJ, DeMaria MA, et al. Fetal RhD genotyping in fetal cells flow sorted from maternal blood. Am J Obstet Gynecol 1996;174: 818-22.